DE69019789D1 - Zusammensetzung für die Diagnose und Behandlung insbesondere von Krebs. - Google Patents

Zusammensetzung für die Diagnose und Behandlung insbesondere von Krebs.

Info

Publication number
DE69019789D1
DE69019789D1 DE69019789T DE69019789T DE69019789D1 DE 69019789 D1 DE69019789 D1 DE 69019789D1 DE 69019789 T DE69019789 T DE 69019789T DE 69019789 T DE69019789 T DE 69019789T DE 69019789 D1 DE69019789 D1 DE 69019789D1
Authority
DE
Germany
Prior art keywords
composition
diagnosis
cancer
treatment
hyalurenectin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69019789T
Other languages
German (de)
English (en)
Inventor
Nicole Girard
Bertrand Delpech
Marie-Noelle Courel
Jean Chomant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Rouen
Original Assignee
Universite de Rouen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Rouen filed Critical Universite de Rouen
Application granted granted Critical
Publication of DE69019789D1 publication Critical patent/DE69019789D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69019789T 1989-08-08 1990-07-18 Zusammensetzung für die Diagnose und Behandlung insbesondere von Krebs. Expired - Lifetime DE69019789D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR898910797A FR2650749B1 (fr) 1989-08-08 1989-08-08 Methode de diagnostic et/ou de traitement, notamment du cancer

Publications (1)

Publication Number Publication Date
DE69019789D1 true DE69019789D1 (de) 1995-07-06

Family

ID=9384654

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69019789T Expired - Lifetime DE69019789D1 (de) 1989-08-08 1990-07-18 Zusammensetzung für die Diagnose und Behandlung insbesondere von Krebs.

Country Status (6)

Country Link
US (1) US5126122A (fr)
EP (1) EP0412920B1 (fr)
AT (1) ATE123229T1 (fr)
CA (1) CA2022755A1 (fr)
DE (1) DE69019789D1 (fr)
FR (1) FR2650749B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3794517B2 (ja) * 1997-05-08 2006-07-05 日本メジフィジックス株式会社 腫瘍診断剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746504A (en) * 1986-03-14 1988-05-24 Bio-Technology General Corp. Heavy metal salts of hyaluronic acid and their use as antimicrobial agents
CA1319593C (fr) * 1987-03-03 1993-06-29 Kenji Chichibu Methode pour l'essai d'acide hyaluronique a poids moleculaire eleve, et trousse de reactifs pour cet essai
DE68923274T2 (de) * 1988-02-09 1995-11-09 Mallinckrodt Inc Verfahren zur herstellung eines mit metall-radionuklid-markierten proteins.
US5015577A (en) * 1989-08-29 1991-05-14 Board Of Regents, The University Of Texas System DNA encoding hyaluronate synthase

Also Published As

Publication number Publication date
FR2650749A1 (fr) 1991-02-15
CA2022755A1 (fr) 1991-02-09
EP0412920A2 (fr) 1991-02-13
EP0412920A3 (fr) 1991-04-03
ATE123229T1 (de) 1995-06-15
EP0412920B1 (fr) 1995-05-31
US5126122A (en) 1992-06-30
FR2650749B1 (fr) 1994-09-02

Similar Documents

Publication Publication Date Title
DE69113129D1 (de) Verfahren und Vorrichtung für die Herstellung von sterilen wässrigen Lösungen.
PT68066A (de) Verfahren zur herstellung von abformmaterialien insbesondere fur die zahnheilkunde.
DE69006565D1 (de) Tampon, insbesondere für die weibliche Hygiene, Verfahren und Vorrichtung für dessen Herstellung.
DE69104796D1 (de) Zusammensetzung für die Haarbehandlung.
HUT59322A (en) Ultrasonic contrast materials, process for producing them and for using them as diagnostic and therepeutic agents
DE3779346D1 (de) Zusammensetzung zur behandlung der haut.
BR7402762D0 (pt) Processo e ferramenta para implantes de corpo
DE69000510D1 (de) Zusammensetzung fuer die behandlung von wasser oder waesserigen systemen.
DE3789079D1 (de) Zusammensetzung für die Behandlung von Fasern.
ATA169289A (de) Schnecke, insbesondere doppelschnecke, für eine schneckenstrangpresse zum verarbeiten von kunststoffen
DE69008945D1 (de) Gerät für die Anwendung von Supraleitfähigkeit.
DE3781652D1 (de) Zubereitung, geeignet fuer die behandlung von darmstoerungen.
ES2017721B3 (es) Tratamiento de material residual acuoso.
BR9006664A (pt) Processo para preparacao de tanino insoluvel,processo para tratamento de residuos usando tanino insoluvel,e processo de adsorcao que usa tanino
AT332695B (de) Vorrichtung zur behandlung, insbesondere zur galvanoplastischen oder reinigungsbehandlung, von teilen
DE69017608D1 (de) Verfahren für die Bestimmung von Distickstoffoxid.
DE69012386D1 (de) Impfstoff und Diagnostikum für den Schweine-Cholera-Virus.
DE68911500D1 (de) Verfahren zur behandlung und diagnose einer ischämischer herzkrankheit.
DE69019789D1 (de) Zusammensetzung für die Diagnose und Behandlung insbesondere von Krebs.
ATA56278A (de) Reaktor fuer kontinuierliches biologisches reinigen von abwasser, insbesondere geeignet fuer wochenendhaeuser, familienhaeuser und dgl.
AT348105B (de) Diagnose-lampe, insbesondere fuer die zahnkontrolle
DE69101847D1 (de) Zubereitung für die Verhütung oder die Behandlung von Hypertriglyceridämie.
DE69018864D1 (de) Neue Benzothiopyranylamine.
DE69013726D1 (de) Verbessertes Verfahren für die Herstellung von o-Carboxypyridyl- und o-Carboxychinolylimidazolinonen.
AT388192B (de) Einrichtung zur behandlung eines materials, insbesondere einer material- bzw. stoffbahn

Legal Events

Date Code Title Description
8332 No legal effect for de